Shri Prayag Texofab Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 26 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 17.55%
- Profit Growth 59.94%
- Ebitda 91.55%
- Net Worth 20.42%
- Total Assets 46.62%
About Shri Prayag Texofab
Shri Prayag Texofab Private Limited (SPTPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 31 December 1998 and has a history of 26 years and one month. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Home & Lifestyle Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pooja Agarwal and Prayank Agrawal serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U17119GJ1998PTC035230
- Company No.
035230
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Dec 1998
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Shri Prayag Texofab?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pooja Agarwal  | Director | 31-Dec-1998 | Current |
| Prayank Agrawal | Director | 31-Dec-1998 | Current |
Financial Performance of Shri Prayag Texofab.
Shri Prayag Texofab Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.55% increase. The company also saw a substantial improvement in profitability, with a 59.94% increase in profit. The company's net worth Soared by an impressive increase of 20.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shri Prayag Texofab?
In 2023, Shri Prayag Texofab had a promoter holding of 52.00% and a public holding of 48.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Atomus Industries Private LimitedPooja Agarwal is a mutual person
- Shri Govind Synthetics Private Limited
Prayank Agrawal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shri Prayag Texofab?
Unlock and access historical data on people associated with Shri Prayag Texofab, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shri Prayag Texofab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shri Prayag Texofab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
